Advanced Search
MyIDEAS: Login to follow this author

Afschin Gandjour

Contents:

This is information that was supplied by Afschin Gandjour in registering through RePEc. If you are Afschin Gandjour , you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name: Afschin
Middle Name:
Last Name: Gandjour
Suffix:

RePEc Short-ID: pga659

Email: [This author has chosen not to make the email address public]
Homepage: http://www.fs.de/gandjour
Postal Address:
Phone:

Affiliation

Frankfurt School of Finance and Management
Location: Frankfurt, Germany
Homepage: http://www.frankfurt-school.de/
Email:
Phone: 069 154008-0
Fax:
Postal: Sonnemannstraße 9-11, 60314 Frankfurt am Main
Handle: RePEc:edi:hfbfide (more details at EDIRC)

Works

as in new window

Articles

  1. Afschin Gandjour, 2012. "Presenting Germany’s drug pricing rule as a cost-per-QALY rule," Health Care Management Science, Springer, vol. 15(2), pages 103-107, June.
  2. Afschin Gandjour, 2012. "Caregivers' Quality of Life and Economic Evaluations," PharmacoEconomics, Springer Healthcare | Adis, vol. 30(9), pages 857-858.
  3. Gandjour, Afschin & Chernyak, Nadja, 2011. "A new prize system for drug innovation," Health Policy, Elsevier, vol. 102(2), pages 170-177.
  4. Afschin Gandjour, 2011. "Germany's Decision Rule for Setting Ceiling Prices of Drugs: A Comparative Analysis with Other Decision Rules," Applied Health Economics and Health Policy, Springer Healthcare | Adis, vol. 9(2), pages 65-71.
  5. Afschin Gandjour, 2011. "Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding?," PharmacoEconomics, Springer Healthcare | Adis, vol. 29(7), pages 555-561.
  6. Dirk Mueller & Afschin Gandjour, 2011. "Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis," Applied Health Economics and Health Policy, Springer Healthcare | Adis, vol. 9(4), pages 259-273.
  7. Afschin Gandjour, 2011. "A Model to Transfer Trial-Based Pharmacoeconomic Analyses to Clinical Practice," PharmacoEconomics, Springer Healthcare | Adis, vol. 29(2), pages 97-105.
  8. Gandjour, Afschin & Gafni, Amiram, 2010. "The additive utility assumption of the QALY model revisited," Journal of Health Economics, Elsevier, vol. 29(2), pages 325-328, March.
  9. Afschin Gandjour, 2010. "A model to predict the cost-effectiveness of disease management programs," Health Economics, John Wiley & Sons, Ltd., vol. 19(6), pages 697-715.
  10. Afschin Gandjour, 2010. "Investment in quality improvement: how to maximize the return," Health Economics, John Wiley & Sons, Ltd., vol. 19(1), pages 31-42.
  11. Kyra C. Kneis & Afschin Gandjour, 2009. "Economic Evaluation of Sinfrontal in the Treatment of Acute Maxillary Sinusitis in Adults," Applied Health Economics and Health Policy, Springer Healthcare | Adis, vol. 7(3), pages 181-191.
  12. Afschin Gandjour, 2009. "Aging diseases - do they prevent preventive health care from saving costs?," Health Economics, John Wiley & Sons, Ltd., vol. 18(3), pages 355-362.
  13. Afschin Gandjour, 2009. "Pharmaceutical Risk-Sharing Agreements," PharmacoEconomics, Springer Healthcare | Adis, vol. 27(5), pages 431-432.
  14. Dirk Mueller & Afschin Gandjour, 2008. "Cost Effectiveness of Ultrasound and Bone Densitometry for Osteoporosis Screening in Post-Menopausal Women," Applied Health Economics and Health Policy, Springer Healthcare | Adis, vol. 6(2-3), pages 113-135.
  15. Afschin Gandjour, 2008. "Mutual dependency between capabilities and functionings in Amartya Sen’s capability approach," Social Choice and Welfare, Springer, vol. 31(2), pages 345-350, August.
  16. Afschin Gandjour, 2008. "Loss Aversion and Cost Effectiveness of Healthcare Programmes," PharmacoEconomics, Springer Healthcare | Adis, vol. 26(11), pages 895-898.
  17. Afschin Gandjour, 2008. "Incorporating feelings related to the uncertainty about future health in utility measurement," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1207-1213.
  18. Afschin Gandjour, 2008. "Assessing the Value of a Future Study," PharmacoEconomics, Springer Healthcare | Adis, vol. 26(10), pages 891-892.
  19. Dirk Mueller & Eva Weyler & Afschin Gandjour, 2008. "Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis," PharmacoEconomics, Springer Healthcare | Adis, vol. 26(6), pages 513-536.
  20. Gandjour, Afschin & Stock, Stephanie, 2007. "A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness," Health Policy, Elsevier, vol. 83(2-3), pages 257-267, October.
  21. Afschin Gandjour, 2006. "Consumption costs and earnings during added years of life - a reply to Nyman," Health Economics, John Wiley & Sons, Ltd., vol. 15(3), pages 315-317.
  22. Afschin Gandjour & Eva-Julia Weyler, 2006. "Cost-effectiveness of referrals to high-volume hospitals: An analysis based on a probabilistic Markov model for hip fracture surgeries," Health Care Management Science, Springer, vol. 9(4), pages 359-369, November.
  23. Afschin Gandjour & Juliette Greb & Eckart Bomsdorf & Karl Wilhelm Lauterbach, 2005. "Impact of Demographic Changes on Healthcare Expenditures and Funding in the EU," Applied Health Economics and Health Policy, Springer Healthcare | Adis, vol. 4(1), pages 1-4.
  24. Gandjour, Afschin & Lauterbach, Karl Wilhelm, 2005. "Does prevention save costs?: Considering deferral of the expensive last year of life," Journal of Health Economics, Elsevier, vol. 24(4), pages 715-724, July.
  25. Afschin Gandjour & Karl W. Lauterbach, 1999. "Review of Quality-of-Life Evaluations in Patients with Angina Pectoris," PharmacoEconomics, Springer Healthcare | Adis, vol. 16(2), pages 141-152.

Statistics

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

Corrections

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Afschin Gandjour should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.